Serum Institute of India (SII) has been served a legal notice by AstraZeneca over vaccine supply delays.
"Astrazeneca has sent us a legal notice (for delays in supplying the vaccine) and the Indian government is also aware of that. I cannot comment on the legal notice as it is confidential, but we are examining all avenues to amicably manage and resolve legal disputes over contractual obligations that Serum Institute is not able to fulfil due to its prioritisation of Indian supplies. Everyone has been very understanding so far. The government is evaluating what it can do to resolve the issue," NDTV reports SII CEO Adar Poonawalla saying during an interview with an Indian media.
Earlier, the CEO had said that Serum's production capacity to manufacture Covishield -- one of the two vaccines being administered in India -- is "very stressed, to put it frankly", amid pressure from soaring cases in the country.
"The globe needs this vaccine and we are prioritising the needs of India at the moment and we are still short of being able to supply... to every Indian that needs it," Poonawalla had said.